SOPYX
Price
$31.96
Change
+$0.19 (+0.60%)
Updated
Jun 6 closing price
Net Assets
8.41B
VIVAX
Price
$67.51
Change
+$0.65 (+0.97%)
Updated
Jun 6 closing price
Net Assets
188.77B
Interact to see
Advertisement

SOPYX vs VIVAX

Header iconSOPYX vs VIVAX Comparison
Open Charts SOPYX vs VIVAXBanner chart's image
ClearBridge Dividend Strategy I
Price$31.96
Change+$0.19 (+0.60%)
VolumeN/A
Net Assets8.41B
Vanguard Value Index I
Price$67.51
Change+$0.65 (+0.97%)
VolumeN/A
Net Assets188.77B
SOPYX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SOPYX vs. VIVAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SOPYX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. SOPYX (8.41B). VIVAX pays higher dividends than SOPYX: VIVAX (2.16) vs SOPYX (1.35). SOPYX was incepted earlier than VIVAX: SOPYX (29 years) vs VIVAX (33 years). SOPYX (0.73) is less costly to investors than VIVAX (0.17). SOPYX is a more actively managed with annual turnover of: 19.00 vs. VIVAX (9.00). VIVAX has a lower initial minimum investment than SOPYX: VIVAX (3000) vs SOPYX (1000000). VIVAX annual gain was more profitable for investors over the last year : 6.81 vs. SOPYX (4.75). VIVAX return over 5 years is better than : 58.70 vs. SOPYX (36.41).
SOPYXVIVAXSOPYX / VIVAX
Total Expense Ratio0.730.17429%
Annual Report Gross Expense Ratio0.730.17429%
Fund Existence29 years33 years-
Gain YTD3.1001.238250%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets8.41B189B4%
Annual Yield % from dividends1.352.1663%
Returns for 1 year4.756.8170%
Returns for 3 years9.4518.5151%
Returns for 5 years36.4158.7062%
Returns for 10 years74.02102.9072%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABUS3.480.08
+2.35%
Arbutus Biopharma Corp
WSFS53.081.21
+2.33%
WSFS Financial Corp
MNSB18.20N/A
N/A
MainStreet Bancshares
PATH13.21-0.05
-0.38%
UiPath
FAMI1.87-0.06
-3.11%
Farmmi Inc